Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dongen, Jurgen Van
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy	Recruiting	4	292	Europe	Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab	Universitaire Ziekenhuizen KU Leuven	Crohn Disease	10/27	10/30
NCT05815602: Ebastine Versus Mebeverine in IBS Patients	Recruiting	3	200	Europe	Ebastine, Duspatalin	Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium	IBS - Irritable Bowel Syndrome, IBS	10/27	01/28
Mestdagh, Inez
NCT05815602: Ebastine Versus Mebeverine in IBS Patients	Recruiting	3	200	Europe	Ebastine, Duspatalin	Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium	IBS - Irritable Bowel Syndrome, IBS	10/27	01/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dongen, Jurgen Van
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy	Recruiting	4	292	Europe	Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab	Universitaire Ziekenhuizen KU Leuven	Crohn Disease	10/27	10/30
NCT05815602: Ebastine Versus Mebeverine in IBS Patients	Recruiting	3	200	Europe	Ebastine, Duspatalin	Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium	IBS - Irritable Bowel Syndrome, IBS	10/27	01/28
Mestdagh, Inez
NCT05815602: Ebastine Versus Mebeverine in IBS Patients	Recruiting	3	200	Europe	Ebastine, Duspatalin	Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium	IBS - Irritable Bowel Syndrome, IBS	10/27	01/28